MAPT and Alzheimer disease: To limit the potential confounding influence of age-related Aβ-independent tau pathology as seen in PART [18], Brodmann’s area 9 of the superior frontal cortex, a region which does not develop NFTs until late-stage AD-related disease progression (Braak NFT V-VI) was selected for investigation.